Pfizer
Pfizer Limited is the Indian subsidiary of Pfizer Inc., marketing 150+ branded pharmaceutical products across 15 therapeutic areas, including vaccines and specialty therapeutics, serving Indian patients and healthcare professionals through field sales, the PfizerPro.in portal, and a Cipla distribution partnership.
- Company typePublic
- Founded1950
- HeadquartersMumbai, India
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pfizer does
Pfizer Limited is the Indian subsidiary of U.S.-based Pfizer Inc., operating as a publicly listed pharmaceutical company (NSE ticker: PFIZER; BSE: 500680) with over 70 years of India operations since 1950. The company markets more than 150 products across 15 therapeutic areas through 4 key business categories, focusing on branded pharmaceuticals, vaccines, and therapeutics, with approximately 70% of India-sold products manufactured domestically. Pfizer Limited generated Q3 FY26 revenue of Rs 645.03 crore (up 19.8% YoY) and Q4 FY26 revenue of Rs 629 crore, operating with a zero-debt balance sheet, 63.46% ROCE, and 35%+ profit margins.
The company uses a hybrid go-to-market combining enterprise field sales targeting hospitals and healthcare professionals (supported by the PfizerPro.in portal) with an exclusive supply and marketing agreement with Cipla Limited for legacy brands Corex Dx, Corex LS, Dolonex, and Neksium. Recent strategic activity includes the December 2025 launch of Rimegepant ODT in the anti-migraine category, hospital partnerships for adult vaccination (Artemis Hospitals), and the Arogya Seva Kendras CSR initiative with Star Health and Piramal Swasthya covering 9 Indian states. Customer segments span end-patients across multiple therapeutic conditions, healthcare professionals served through dedicated medical-information channels, and specialty care patients in categories such as migraine. Pfizer Limited is operationally influenced by global Pfizer Inc. decisions, including a December 2025/FY26 personnel restructuring with Rs 41.73 crore in exceptional separation costs and parent-level divestiture of Haleon in March 2025.
Pfizer firmographics
Firmographics- Name
- Pfizer
- Legal name
- Pfizer Limited
- Website
- https://pfizerindia.com
- Company type
- Public
- Founded year
- 1950
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Pfizer Limited is the Indian subsidiary of Pfizer Inc., marketing 150+ branded pharmaceutical products across 15 therapeutic areas, including vaccines and specialty therapeutics, serving Indian patients and healthcare professionals through field sales, the PfizerPro.in portal, and a Cipla distribution partnership.
- Ownership category
- akta.pro rank
Pfizer industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)
Keywords
Where Pfizer is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Pfizer business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Pfizer India generates revenue through the sale of pharmaceutical products across 15 therapeutic areas with over 150 products in 4 key business categories. The company has a strong focus on branded products, vaccines, and therapeutics.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Pfizer product offering
Product offeringCore offering
Pfizer Limited manufactures and markets a portfolio of more than 150 pharmaceutical products across 15 therapeutic areas through 4 key business categories, including branded medicines, vaccines, and therapeutics. Its offerings include the anti-migraine medication Rimegepant ODT launched in December 2025 and brands such as Corex Dx, Corex LS, Dolonex, and Neksium distributed through an exclusive supply and marketing agreement with Cipla.
Product overview
Pfizer Limited operates as a pharmaceutical company offering a diverse portfolio of over 150 products across 15 therapeutic areas through 4 key business categories. The product portfolio includes branded pharmaceutical products such as migraine medication (Rimegepant ODT), and brands under strategic partnerships (Corex Dx, Corex LS, Dolonex, Neksium via Cipla agreement). The company focuses on vaccines and therapeutics, with products spanning multiple therapeutic categories.
Differentiator
Problem solved
Functional benefit
Products and services
- Rimegepant ODT Anti-migraine medication for adults with insufficient response to triptan drugs, sold to healthcare providers and dispensed to patients in India.
- Corex Dx Pharmaceutical brand under exclusive supply and marketing agreement with Cipla Limited in India.
- Corex LS Pharmaceutical brand under exclusive supply and marketing agreement with Cipla Limited in India.
- Dolonex Pharmaceutical brand under exclusive supply and marketing agreement with Cipla Limited in India.
- Neksium Pharmaceutical brand under exclusive supply and marketing agreement with Cipla Limited in India.
- Pfizer Limited Product Portfolio Comprehensive portfolio of more than 150 branded pharmaceutical products across 15 therapeutic areas and 4 key business categories, including vaccines, therapeutics, and other branded medicines sold to healthcare providers in India.
Quantifiable outcome
- 19.8% YoY revenue growth in Q3FY26
- +3 more outcomes
Companies that use Pfizer
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Pfizer technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pfizer partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and major.
- Star Health and Allied Insurance Company LimitedcorePfizer India is contributing vaccination expertise to Star Health's Arogya Seva Kendras CSR program, providing free primary healthcare including adult pneumococcal vaccination. The initiative operates across 9 Indian states including Chennai, Mysuru, Hyderabad, Bhubaneswar, Punjab, UP, West Bengal, and Maharashtra.
- Piramal SwasthyacorePartnership with Piramal Swasthya for the Arogya Seva Kendras initiative under Star Health's CSR program to provide free primary healthcare services to over a million lives.
- Cipla LimitedcoreExclusive supply and marketing agreement with Cipla Limited for Pfizer's brands Corex Dx, Corex LS, Dolonex, and Neksium. This partnership includes exceptional costs of Rs 41.73 crore for personnel separation linked to this agreement.
- Summit TherapeuticsmajorPfizer to test Summit Therapeutics' bispecific with ADCs as part of cancer treatment development collaboration. Partnership evaluated for potential in cancer drug development.
- PAHO, Argentina, SinergiummajorPfizer partnership with PAHO, Argentina, and Sinergium to drive local production of 20-valent pneumococcal vaccine for Latin America and the Caribbean.
- Artemis HospitalscoreLaunch of Centre for Adult Vaccination with Artemis Hospitals, providing specialized vaccination services for adults including pneumococcal vaccination.
Scale indicators16 records
Recent moves7 records
Expansion highlights6 records
Pfizer competitors and assessment
Company assessmentDirect peers
- Cipla Limited: India's largest domestic pharma company by some metrics and Pfizer India's exclusive distribution partner since December 2025 for Corex Dx, Corex LS, Dolonex, and Neksium. Directly comparable business model with branded generics across multiple therapeutic areas in India.
- Glenmark Pharmaceuticals: India-domiciled pharma with branded specialty/generic portfolio. Comparable in therapy-area breadth and HCP field-sales model, though typically positioned at a smaller revenue scale than Pfizer India.
- Dr. Reddy's Laboratories: Major Indian-headquartered pharma with a comparable branded generics portfolio plus emerging specialty/biologics presence. Competes directly with Pfizer India in cardiology, oncology, and primary care therapy areas.
- Lupin Limited: Top-5 Indian pharma with branded and generic formulations across cardiovascular, diabetes, and respiratory areas. Directly comparable in scale, India-centric commercial model, and HCP-targeted field sales motion.
- Torrent Pharmaceuticals: Mid-cap Indian pharma with branded formulations across therapeutic areas. Comparable in size, branded-generic strategy, and India-focused commercial execution to Pfizer Limited India.
- Sun Pharmaceutical Industries: India's largest pharmaceutical company by revenue, with a comparable branded formulations portfolio spanning multiple therapeutic areas. Both companies compete for the same HCP mind-share and retail pharmacy shelf space across India.
- Abbott India Limited: Indian subsidiary of Abbott Laboratories with a nearly identical structural profile to Pfizer Limited: MNC pharma subsidiary, broad therapy-area branded portfolio, and NSE/BSE-listed public company. Direct comparable for MNC pharma India model analysis.
- GSK Pharmaceuticals India (now part of Hetero/BSV): MNC pharma subsidiary operating in India with branded specialty and vaccine portfolios. Closely mirrors Pfizer India's MNC pharma India business model, including vaccines and specialty launches.
- Novartis India: Indian arm of Novartis with specialty pharma focus including neurology and cardiology. Comparable as a Swiss MNC pharma subsidiary operating in India with similar portfolio breadth and HCP-engagement model.
- Sanofi India: MNC pharma subsidiary with similar branded specialty franchises including diabetes/cardiovascular. Operates with comparable India-focused commercial structure, HCP sales force, and listed-entity dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Pfizer social profiles
Digital presencePfizer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pfizer leadership team
Management profileNumber of profiles
Profiles4 records
Pfizer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pfizer M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pfizer
What does Pfizer do?
Pfizer Limited manufactures and markets a portfolio of more than 150 pharmaceutical products across 15 therapeutic areas through 4 key business categories, including branded medicines, vaccines, and therapeutics. Its offerings include the anti-migraine medication Rimegepant ODT launched in December 2025 and brands such as Corex Dx, Corex LS, Dolonex, and Neksium distributed through an exclusive supply and marketing agreement with Cipla.
Is Pfizer a public or private company?
Pfizer is a public company. It is classified as public and is currently operating.
When was Pfizer founded?
Pfizer was founded in 1950. It employs 5,001 to 10,000 people.
Where is Pfizer based?
Pfizer is headquartered in Mumbai, India, in the Asia region.
How does Pfizer make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Pfizer's main competitors?
Direct peers on record are Cipla Limited, Glenmark Pharmaceuticals, Dr. Reddy's Laboratories, Lupin Limited, Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Abbott India Limited, GSK Pharmaceuticals India (now part of Hetero/BSV), Novartis India and Sanofi India.
Does Pfizer have an API?
No public API is recorded for Pfizer.
What industry is Pfizer in?
Pfizer's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIACAC, Neurology & CNS Specialty Pharmaceuticals. Its NAICS code is 32541 and its SIC code is 2834.